Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| MF | GO:0004674 | protein serine/threonine kinase activity | 93/2603 | 439/17697 | 0.0001372 | 0.009808 | 0.008718 | 93 | RABC86 | |
| MF | GO:0009055 | electron transfer activity | 32/2603 | 114/17697 | 0.0001646 | 0.01108 | 0.009846 | 32 | RABC86 | |
| MF | GO:0004896 | cytokine receptor activity | 28/2603 | 96/17697 | 0.0002039 | 0.01296 | 0.01152 | 28 | RABC86 | |
| MF | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 16/2603 | 43/17697 | 0.0002315 | 0.01394 | 0.01239 | 16 | RABC86 | |
| MF | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 17/2603 | 49/17697 | 0.0003931 | 0.02249 | 0.01999 | 17 | RABC86 | |
| MF | GO:1901681 | sulfur compound binding | 56/2603 | 250/17697 | 0.0006983 | 0.03655 | 0.03249 | 56 | RABC86 | |
| MF | GO:0035091 | phosphatidylinositol binding | 55/2603 | 245/17697 | 0.0007338 | 0.03655 | 0.03249 | 55 | RABC86 | |
| MF | GO:0005539 | glycosaminoglycan binding | 52/2603 | 229/17697 | 0.0007649 | 0.03655 | 0.03249 | 52 | RABC86 | |
| MF | GO:0051287 | NAD binding | 18/2603 | 56/17697 | 0.0007668 | 0.03655 | 0.03249 | 18 | RABC86 | |
| MF | GO:0042605 | peptide antigen binding | 12/2603 | 31/17697 | 0.0009196 | 0.04208 | 0.0374 | 12 | RABC86 | |
| BP | GO:0042110 | T cell activation | 137/2112 | 464/18670 | 2.97e-27 | 1.84e-23 | 1.33e-23 | 137 | RABC51 | |
| BP | GO:0045785 | positive regulation of cell adhesion | 120/2112 | 403/18670 | 2.42e-24 | 7.48e-21 | 5.41e-21 | 120 | RABC51 | |
| BP | GO:0007159 | leukocyte cell-cell adhesion | 106/2112 | 337/18670 | 1.08e-23 | 2.13e-20 | 1.54e-20 | 106 | RABC51 | |
| BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 81/2112 | 218/18670 | 1.38e-23 | 2.13e-20 | 1.54e-20 | 81 | RABC51 | |
| BP | GO:0050870 | positive regulation of T cell activation | 77/2112 | 202/18670 | 2.7e-23 | 3.34e-20 | 2.41e-20 | 77 | RABC51 | |
| BP | GO:0050863 | regulation of T cell activation | 99/2112 | 314/18670 | 2.71e-22 | 2.8e-19 | 2.02e-19 | 99 | RABC51 | |
| BP | GO:0051249 | regulation of lymphocyte activation | 131/2112 | 485/18670 | 3.4e-22 | 3e-19 | 2.17e-19 | 131 | RABC51 | |
| BP | GO:0022409 | positive regulation of cell-cell adhesion | 86/2112 | 255/18670 | 1.11e-21 | 8.56e-19 | 6.19e-19 | 86 | RABC51 | |
| BP | GO:0050867 | positive regulation of cell activation | 112/2112 | 394/18670 | 5.15e-21 | 3.54e-18 | 2.56e-18 | 112 | RABC51 | |
| BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 94/2112 | 304/18670 | 1.44e-20 | 8.88e-18 | 6.41e-18 | 94 | RABC51 | |
| BP | GO:0002696 | positive regulation of leukocyte activation | 108/2112 | 380/18670 | 2.68e-20 | 1.51e-17 | 1.09e-17 | 108 | RABC51 | |
| BP | GO:0051251 | positive regulation of lymphocyte activation | 97/2112 | 334/18670 | 4.61e-19 | 2.37e-16 | 1.72e-16 | 97 | RABC51 | |
| BP | GO:0022407 | regulation of cell-cell adhesion | 109/2112 | 403/18670 | 1.06e-18 | 5.04e-16 | 3.64e-16 | 109 | RABC51 | |
| BP | GO:0046651 | lymphocyte proliferation | 84/2112 | 272/18670 | 1.77e-18 | 7.75e-16 | 5.6e-16 | 84 | RABC51 | |
| BP | GO:0070661 | leukocyte proliferation | 89/2112 | 298/18670 | 1.88e-18 | 7.75e-16 | 5.6e-16 | 89 | RABC51 | |
| BP | GO:0030098 | lymphocyte differentiation | 99/2112 | 353/18670 | 2.87e-18 | 0.00000000000000106 | 7.68e-16 | 99 | RABC51 | |
| BP | GO:0032943 | mononuclear cell proliferation | 84/2112 | 274/18670 | 2.92e-18 | 0.00000000000000106 | 7.68e-16 | 84 | RABC51 | |
| BP | GO:0071346 | cellular response to interferon-gamma | 63/2112 | 180/18670 | 3.84e-17 | 0.0000000000000132 | 0.00000000000000952 | 63 | RABC51 | |
| BP | GO:0030217 | T cell differentiation | 75/2112 | 240/18670 | 5.84e-17 | 0.000000000000019 | 0.0000000000000137 | 75 | RABC51 | |
| BP | GO:0050670 | regulation of lymphocyte proliferation | 68/2112 | 208/18670 | 1.26e-16 | 0.0000000000000372 | 0.0000000000000269 | 68 | RABC51 |